Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Government regulations affect drug development, often prolonging the process, but they ensure safety and efficacy to protect ...
Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.
SandboxAQ is a company that many pharma and biotech professionals will be keeping an extremely close eye on in the coming years. Having SandboxAQ emerged as an independent company following spin-off ...
Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices. The pharmaceutical industry, known for its rigorous research, complex ...
The Chosun Ilbo on MSN
NVIDIA, Eli Lilly partner on physical AI drug development
On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...
24/7 Wall St. on MSN
Eli Lilly and Nvidia make $1 billion AI bet to revolutionize pharma’s future
Quick Read Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years in an AI drug discovery lab. AI could ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
In Silicon Valley, scientific altruism meets entrepreneurship in the race for ne A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results